Preemptive Paracetamol for Postoperative Pain (PPPP)
Primary Purpose
Pain, Surgical Wound
Status
Unknown status
Phase
Phase 4
Locations
Study Type
Interventional
Intervention
Intravenous paracetamol
Intravenous saline 0.9%
Sponsored by
About this trial
This is an interventional treatment trial for Pain
Eligibility Criteria
Inclusion Criteria:
- Aged 18-80 years old
- Patients listed for non-malignant cervical spinal surgery
- General anaesthesia
- Capacity to give informed consent
- Ability to use PCA device and pain score scale
- ASA I, II and III
- >50kg in weight
Exclusion Criteria:
- Allergy or sensitivity to paracetamol, proparacetamol or morphine
- Liver disease
- Renal disease (creatinine clearance <30ml/min)
- Bleeding disorder
- Chronic alcoholism
- Chronic malnutrition
- Dehydration
- G6PD deficiency
- Hypernatraemia (Na >150)
- Hypokalaemia (K <3.5) and hyperchloraemia
- Pregnancy or breast-feeding
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Preemptive paracetamol
Postincision paracetamol
Arm Description
1000mg intravenous paracetamol given ≥15 minutes before surgical incision and intravenous saline 15 minutes before the end of surgery
Intravenous saline ≥15 minutes before surgical incision and 1000mg intravenous paracetamol given 15 minutes before the end of surgery
Outcomes
Primary Outcome Measures
Morphine consumption
Measured from PCA machine
Secondary Outcome Measures
Time to first analgesic request
In minutes
Nausea and vomiting
Incidence of nausea or vomiting 24 hours postoperatively
Pruritus
Incidence of pruritus 24 hours postoperatively
Sedation
Incidence of sedation 24 hours postoperatively
Urinary retention
Incidence of urinary retention 24 hours postoperatively
Allergic reaction
Incidence of allergic reaction (defined as diagnosed by clinician 24 hours postoperatively)
Pain score
Numeric rating scale (NRS)
Pain score
Numeric rating scale (NRS)
Pain score
Numeric rating scale (NRS)
Pain score
Numeric rating scale (NRS)
Pain score
Numeric rating scale (NRS)
Full Information
NCT ID
NCT02425254
First Posted
April 9, 2015
Last Updated
December 2, 2015
Sponsor
University of Nottingham
1. Study Identification
Unique Protocol Identification Number
NCT02425254
Brief Title
Preemptive Paracetamol for Postoperative Pain
Acronym
PPPP
Official Title
Preemptive Paracetamol for Postoperative Pain: a Randomised, Double-blind, Two Way Crossover Trial
Study Type
Interventional
2. Study Status
Record Verification Date
December 2015
Overall Recruitment Status
Unknown status
Study Start Date
January 2016 (undefined)
Primary Completion Date
June 2017 (Anticipated)
Study Completion Date
July 2018 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Nottingham
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to test whether a dose of paracetamol given before surgical incision is more effective at reducing postoperative pain and analgesic consumption in cervical spine surgery versus a dose given at the end of surgery.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pain, Surgical Wound
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Crossover Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
50 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Preemptive paracetamol
Arm Type
Experimental
Arm Description
1000mg intravenous paracetamol given ≥15 minutes before surgical incision and intravenous saline 15 minutes before the end of surgery
Arm Title
Postincision paracetamol
Arm Type
Active Comparator
Arm Description
Intravenous saline ≥15 minutes before surgical incision and 1000mg intravenous paracetamol given 15 minutes before the end of surgery
Intervention Type
Drug
Intervention Name(s)
Intravenous paracetamol
Intervention Description
1000mg intravenous solution for infusion
Intervention Type
Drug
Intervention Name(s)
Intravenous saline 0.9%
Intervention Description
0.9% sodium chloride in order to ensure double-blinding
Primary Outcome Measure Information:
Title
Morphine consumption
Description
Measured from PCA machine
Time Frame
24 hours postoperatively
Secondary Outcome Measure Information:
Title
Time to first analgesic request
Description
In minutes
Time Frame
24 hours
Title
Nausea and vomiting
Description
Incidence of nausea or vomiting 24 hours postoperatively
Time Frame
24 hours
Title
Pruritus
Description
Incidence of pruritus 24 hours postoperatively
Time Frame
24 hours
Title
Sedation
Description
Incidence of sedation 24 hours postoperatively
Time Frame
24 hours
Title
Urinary retention
Description
Incidence of urinary retention 24 hours postoperatively
Time Frame
24 hours
Title
Allergic reaction
Description
Incidence of allergic reaction (defined as diagnosed by clinician 24 hours postoperatively)
Time Frame
24 hours
Title
Pain score
Description
Numeric rating scale (NRS)
Time Frame
1 hour
Title
Pain score
Description
Numeric rating scale (NRS)
Time Frame
2 hours
Title
Pain score
Description
Numeric rating scale (NRS)
Time Frame
6 hours
Title
Pain score
Description
Numeric rating scale (NRS)
Time Frame
12 hours
Title
Pain score
Description
Numeric rating scale (NRS)
Time Frame
24 hours
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Aged 18-80 years old
Patients listed for non-malignant cervical spinal surgery
General anaesthesia
Capacity to give informed consent
Ability to use PCA device and pain score scale
ASA I, II and III
>50kg in weight
Exclusion Criteria:
Allergy or sensitivity to paracetamol, proparacetamol or morphine
Liver disease
Renal disease (creatinine clearance <30ml/min)
Bleeding disorder
Chronic alcoholism
Chronic malnutrition
Dehydration
G6PD deficiency
Hypernatraemia (Na >150)
Hypokalaemia (K <3.5) and hyperchloraemia
Pregnancy or breast-feeding
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
John Williams, PhD
Phone
01332 724641
Email
john.williams7@nottingham.ac.uk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
John Williams
Organizational Affiliation
University of Nottiongham
Official's Role
Principal Investigator
12. IPD Sharing Statement
Learn more about this trial
Preemptive Paracetamol for Postoperative Pain
We'll reach out to this number within 24 hrs